Clinical Trial Update: Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial of allogeneic mesenchymal stem cell-derived exosome therapy for progressive multiple sclerosis has been suspended. Sponsor Biocells Medical is a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy

Snippet

Sponsor: Biocells Medical | Conditions: Multiple Sclerosis | EARLY_Phase 1 | Status: SUSPENDED